Higher Heart Rate May Help Spur A-fib in Black Patients

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 5, 2024.

By Dennis Thompson HealthDay Reporter

TUESDAY, Nov. 5, 2024 -- An elevated heart rate could provide an important clue to which Black adults often have a dangerous heart rhythm disorder, a new study finds.

Higher resting heart rate is associated with increased risk of atrial fibrillation, researchers found.

What’s more, the higher a person’s heart rate, the higher their risk for A-fib, results showed.

Every 10-beats-per-minute increase in heart rate is associated with a 9% higher risk of developing afib, researchers reported recently in the journal JAMA Network Open.

This study is the first to look specifically at A-fib risk among Black patients, said lead researcher Dr. Vid Yogeswaran, a cardiologist with the University of Washington School of Medicine in Seattle.

“This study is useful because, among Black adults, we know little about risk factors for cardiovascular disease -- and specifically for A-fib, which can lead to heart failure, stroke, dementia and death,” Yogeswaran said in a university news release.

“Paradoxically, Black adults have a lower reported clinical prevalence of atrial fibrillation than white adults, but have a much higher risk of A-Fib-associated consequences such as stroke and death,” Yogeswaran added.

With A-fib, the upper chambers of the heart, called the atria, start to beat irregularly.

This allows blood to pool and potentially clot in the atria, increasing a person’s risk of stroke.

Untreated A-fib raises a person’s risk of stroke fivefold, and also doubles the risk of heart-related death, according to the American Heart Association.

For their report, researchers analyzed data from the Jackson Heart Study, a long-term research project tracking the heart health of adult Black patients in Jackson, Miss.

They followed nearly 5,000 people who had no A-fib diagnosis as of 2000, to see if they developed the heart rhythm disorder by 2016.

The average resting heart rate among patients at the beginning of the study was 65 beats per minute.

During the follow-up period, more than 450 patients developed A-fib -- and an increase in their heart rate over time was linked to their risk of the disorder, researchers found.

Further, the association between resting heart rate and A-fib persisted even after researchers accounted for other risk factors like age, high blood pressure, elevated BMI and lack of exercise.

Previous studies of A-fib have mostly focused on people of European descent, and the relationship between heart rate and the disorder has not been clear among Black patients, the researchers noted.

“Some studies say it's only low [resting heart rate that poses risk for A-Fib]. Some studies say it's only high. None of the studies has been powered enough to detect the resting heart-rate risk among Black adults,” Yogeswaran said.

“Our paper shows that high resting heart rate is the risk among Black adults,” Yogeswaran concluded.

However, more research is needed to determine whether resting heart rate can serve as a useful screening tool for A-fib among Black patients, researchers noted.

Sources

  • University of Washington, news release, Oct. 30, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-11-06 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords